25 XP   0   0   10

Zhejiang Medicine Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Medicine Co Ltd together

PenkeI guess you are interested in Zhejiang Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Medicine Co Ltd

I send you an email if I find something interesting about Zhejiang Medicine Co Ltd.

Quick analysis of Zhejiang Medicine Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Medicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.03
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.43
Expected worth in 1 year
¥10.69
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.45
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
¥11.02
Expected price per share
¥9.99 - ¥11.46
How sure are you?
50%

1. Valuation of Zhejiang Medicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥11.02

Intrinsic Value Per Share

¥-7.04 - ¥-1.70

Total Value Per Share

¥3.39 - ¥8.73

2. Growth of Zhejiang Medicine Co Ltd (5 min.)




Is Zhejiang Medicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.3b$1.3b$56.6m4.1%

How much money is Zhejiang Medicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$14.7m$13.5m$1.1m7.8%
Net Profit Margin5.3%5.0%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Medicine Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Medicine Co Ltd? (5 min.)

Welcome investor! Zhejiang Medicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Medicine Co Ltd.

What can you expect buying and holding a share of Zhejiang Medicine Co Ltd?

First you should know what it really means to hold a share of Zhejiang Medicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Medicine Co Ltd is ¥11.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Medicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Medicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.43. Based on the TTM, the Book Value Change Per Share is ¥0.06 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Medicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.1%0.020.1%0.020.2%0.020.2%0.020.2%
Usd Book Value Change Per Share0.010.1%0.010.1%0.020.1%0.010.1%0.010.1%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%0.020.1%0.030.3%0.030.3%0.020.2%
Usd Price Per Share1.24-1.45-1.77-1.89-1.76-
Price to Earnings Ratio19.67-37.29-24.17-14.25-44.29-
Price-to-Total Gains Ratio99.41-7,477.56-62.56-1,607.68-1,760.92-
Price to Book Ratio0.86-1.01-1.29-1.50-1.55-
Price-to-Total Gains Ratio99.41-7,477.56-62.56-1,607.68-1,760.92-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.525168
Number of shares655
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.01
Usd Total Gains Per Share0.020.03
Gains per Quarter (655 shares)10.2418.26
Gains per Year (655 shares)40.9873.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1182331373663
23646727472136
35469113112107209
47292154149143282
590115195186179355
6108138236223215428
7126161277261251501
8144184318298286574
9162207359335322647
10180230400372358720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%35.02.03.087.5%82.02.05.092.1%
Book Value Change Per Share3.01.00.075.0%10.02.00.083.3%17.03.00.085.0%30.010.00.075.0%70.019.00.078.7%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%68.00.021.076.4%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%36.04.00.090.0%82.07.00.092.1%

Fundamentals of Zhejiang Medicine Co Ltd

About Zhejiang Medicine Co Ltd

Zhejiang Medicine Co., Ltd manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company provides injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products. The company was founded in 1997 and is based in Shaoxing, China.

Fundamental data was last updated by Penke on 2024-05-12 04:27:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Medicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Medicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 4.9% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 4.9%. The company is making a profit. +1
  • The TTM is 5.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.9%TTM5.3%-0.4%
TTM5.3%YOY5.0%+0.4%
TTM5.3%5Y7.5%-2.1%
5Y7.5%10Y6.6%+0.9%
1.1.2. Return on Assets

Shows how efficient Zhejiang Medicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Assets means that Zhejiang Medicine Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 0.8%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%+0.0%
TTM0.8%YOY0.8%+0.0%
TTM0.8%5Y1.3%-0.5%
5Y1.3%10Y1.1%+0.2%
1.1.3. Return on Equity

Shows how efficient Zhejiang Medicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.1% Return on Equity means Zhejiang Medicine Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 1.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.1%TTM1.1%+0.0%
TTM1.1%YOY1.1%+0.0%
TTM1.1%5Y1.8%-0.7%
5Y1.8%10Y1.5%+0.3%

1.2. Operating Efficiency of Zhejiang Medicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Medicine Co Ltd is operating .

  • Measures how much profit Zhejiang Medicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.8%-0.8%
TTM0.8%YOY2.5%-1.7%
TTM0.8%5Y6.9%-6.1%
5Y6.9%10Y3.4%+3.4%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Medicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.61 means that the operating costs are ¥1.61 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 1.608. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.659. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.608TTM1.659-0.051
TTM1.659YOY1.608+0.051
TTM1.6595Y1.537+0.122
5Y1.53710Y1.217+0.321

1.3. Liquidity of Zhejiang Medicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Medicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.38 means the company has ¥2.38 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 2.376. The company is able to pay all its short-term debts. +1
  • The TTM is 2.263. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.376TTM2.263+0.113
TTM2.263YOY2.274-0.011
TTM2.2635Y2.318-0.055
5Y2.31810Y1.431+0.888
1.3.2. Quick Ratio

Measures if Zhejiang Medicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.74 means the company can pay off ¥0.74 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 0.742. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.701. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.742TTM0.701+0.040
TTM0.701YOY0.754-0.052
TTM0.7015Y0.808-0.106
5Y0.80810Y0.884-0.076

1.4. Solvency of Zhejiang Medicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Medicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Medicine Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.22 means that Zhejiang Medicine Co Ltd assets are financed with 22.0% credit (debt) and the remaining percentage (100% - 22.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 0.220. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.215. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.220TTM0.215+0.005
TTM0.215YOY0.226-0.011
TTM0.2155Y0.235-0.020
5Y0.23510Y0.213+0.022
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Medicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 29.2% means that company has ¥0.29 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Medicine Co Ltd:

  • The MRQ is 0.292. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.285. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.292TTM0.285+0.007
TTM0.285YOY0.307-0.022
TTM0.2855Y0.323-0.038
5Y0.32310Y0.282+0.041

2. Market Valuation of Zhejiang Medicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Medicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 19.67 means the investor is paying ¥19.67 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Medicine Co Ltd:

  • The EOD is 24.245. Based on the earnings, the company is fair priced.
  • The MRQ is 19.669. Based on the earnings, the company is fair priced.
  • The TTM is 37.291. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD24.245MRQ19.669+4.576
MRQ19.669TTM37.291-17.621
TTM37.291YOY24.172+13.118
TTM37.2915Y14.251+23.040
5Y14.25110Y44.295-30.044
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Medicine Co Ltd:

  • The EOD is -18.033. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.629. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -99.159. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.033MRQ-14.629-3.404
MRQ-14.629TTM-99.159+84.530
TTM-99.159YOY-114.856+15.697
TTM-99.1595Y-33.440-65.718
5Y-33.44010Y-21.194-12.246
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Medicine Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Medicine Co Ltd:

  • The EOD is 1.056. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.857. Based on the equity, the company is cheap. +2
  • The TTM is 1.008. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.056MRQ0.857+0.199
MRQ0.857TTM1.008-0.151
TTM1.008YOY1.290-0.282
TTM1.0085Y1.496-0.488
5Y1.49610Y1.546-0.050
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0830.063+31%0.111-25%0.099-16%0.091-8%
Book Value Per Share--10.43210.369+1%9.943+5%9.304+12%8.376+25%
Current Ratio--2.3762.263+5%2.274+4%2.318+2%1.431+66%
Debt To Asset Ratio--0.2200.215+2%0.226-3%0.235-6%0.213+4%
Debt To Equity Ratio--0.2920.285+2%0.307-5%0.323-10%0.282+3%
Dividend Per Share--0.0070.050-86%0.092-92%0.103-93%0.080-91%
Eps--0.1140.110+3%0.140-19%0.166-31%0.125-9%
Free Cash Flow Per Share---0.153-0.028-82%-0.035-77%0.008-1941%-0.065-58%
Free Cash Flow To Equity Per Share---0.153-0.017-89%-0.007-95%-0.014-91%-0.040-74%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Intrinsic Value_10Y_max---1.704--------
Intrinsic Value_10Y_min---7.042--------
Intrinsic Value_1Y_max---0.151--------
Intrinsic Value_1Y_min---0.336--------
Intrinsic Value_3Y_max---0.470--------
Intrinsic Value_3Y_min---1.336--------
Intrinsic Value_5Y_max---0.806--------
Intrinsic Value_5Y_min---2.686--------
Market Cap10634024235.520+19%8626876500.00010081576312.500-14%12360876860.000-30%13207773595.972-35%12291931794.018-30%
Net Profit Margin--0.0490.053-8%0.050-2%0.075-35%0.066-26%
Operating Margin---0.008-100%0.025-100%0.069-100%0.034-100%
Operating Ratio--1.6081.659-3%1.608+0%1.537+5%1.217+32%
Pb Ratio1.056+19%0.8571.008-15%1.290-34%1.496-43%1.546-45%
Pe Ratio24.245+19%19.66937.291-47%24.172-19%14.251+38%44.295-56%
Price Per Share11.020+19%8.94010.448-14%12.808-30%13.686-35%12.737-30%
Price To Free Cash Flow Ratio-18.033-23%-14.629-99.159+578%-114.856+685%-33.440+129%-21.194+45%
Price To Total Gains Ratio122.534+19%99.4067477.558-99%62.564+59%1607.682-94%1760.919-94%
Quick Ratio--0.7420.701+6%0.754-2%0.808-8%0.884-16%
Return On Assets--0.0080.008+2%0.008+7%0.013-35%0.011-23%
Return On Equity--0.0110.011+2%0.011+5%0.018-38%0.015-24%
Total Gains Per Share--0.0900.113-20%0.203-56%0.201-55%0.171-47%
Usd Book Value--1393197288.6861384754089.596+1%1328140390.042+5%1242661725.301+12%1118643790.524+25%
Usd Book Value Change Per Share--0.0110.009+31%0.015-25%0.014-16%0.013-8%
Usd Book Value Per Share--1.4441.435+1%1.376+5%1.288+12%1.159+25%
Usd Dividend Per Share--0.0010.007-86%0.013-92%0.014-93%0.011-91%
Usd Eps--0.0160.015+3%0.019-19%0.023-31%0.017-9%
Usd Free Cash Flow---20403830.924-3768760.294-82%-4619684.223-77%1108365.954-1941%-7543878.912-63%
Usd Free Cash Flow Per Share---0.021-0.004-82%-0.005-77%0.001-1941%-0.009-58%
Usd Free Cash Flow To Equity Per Share---0.021-0.002-89%-0.001-95%-0.002-91%-0.006-74%
Usd Market Cap1471748954.196+19%1193959707.6001395290161.650-14%1710745357.424-30%1827955865.683-35%1701203360.292-30%
Usd Price Per Share1.525+19%1.2371.446-14%1.773-30%1.894-35%1.763-30%
Usd Profit--15175509.94214730514.574+3%13583225.124+12%21115637.613-28%16170820.550-6%
Usd Revenue--311284362.260278023985.312+12%274708350.520+13%276387924.952+13%233895682.342+33%
Usd Total Gains Per Share--0.0120.016-20%0.028-56%0.028-55%0.024-47%
 EOD+5 -3MRQTTM+17 -18YOY+14 -215Y+9 -2610Y+9 -27

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1524.245
Price to Book Ratio (EOD)Between0-11.056
Net Profit Margin (MRQ)Greater than00.049
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.742
Current Ratio (MRQ)Greater than12.376
Debt to Asset Ratio (MRQ)Less than10.220
Debt to Equity Ratio (MRQ)Less than10.292
Return on Equity (MRQ)Greater than0.150.011
Return on Assets (MRQ)Greater than0.050.008
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.309
Ma 20Greater thanMa 509.683
Ma 50Greater thanMa 1009.578
Ma 100Greater thanMa 2009.898
OpenGreater thanClose11.260
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets12,909,768
Total Liabilities2,843,314
Total Stockholder Equity9,738,930
 As reported
Total Liabilities 2,843,314
Total Stockholder Equity+ 9,738,930
Total Assets = 12,909,768

Assets

Total Assets12,909,768
Total Current Assets5,666,395
Long-term Assets7,243,373
Total Current Assets
Cash And Cash Equivalents 1,584,294
Short-term Investments 287,324
Net Receivables 1,481,523
Inventory 1,813,790
Other Current Assets 75,294
Total Current Assets  (as reported)5,666,395
Total Current Assets  (calculated)5,242,225
+/- 424,170
Long-term Assets
Property Plant Equipment 6,071,422
Goodwill 18,680
Intangible Assets 728,667
Long-term Assets Other 71,859
Long-term Assets  (as reported)7,243,373
Long-term Assets  (calculated)6,890,628
+/- 352,745

Liabilities & Shareholders' Equity

Total Current Liabilities2,385,152
Long-term Liabilities458,162
Total Stockholder Equity9,738,930
Total Current Liabilities
Short Long Term Debt 235,259
Accounts payable 1,149,272
Other Current Liabilities 4,221
Total Current Liabilities  (as reported)2,385,152
Total Current Liabilities  (calculated)1,388,752
+/- 996,400
Long-term Liabilities
Long term Debt 376,356
Capital Lease Obligations Min Short Term Debt336
Long-term Liabilities  (as reported)458,162
Long-term Liabilities  (calculated)376,691
+/- 81,470
Total Stockholder Equity
Retained Earnings 5,144,340
Total Stockholder Equity (as reported)9,738,930
Total Stockholder Equity (calculated)5,144,340
+/- 4,594,590
Other
Capital Stock964,975
Common Stock Shares Outstanding 964,975
Net Invested Capital 10,350,545
Net Working Capital 3,281,243
Property Plant and Equipment Gross 6,071,422



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
1,604,303
1,436,634
1,599,494
1,565,155
1,615,856
1,732,601
1,783,098
1,636,672
1,816,465
1,680,187
1,705,059
1,668,813
1,827,648
1,793,096
1,895,573
1,838,923
1,943,401
2,121,793
2,136,355
2,207,796
2,386,386
2,532,588
2,569,483
2,528,381
2,590,968
2,693,320
2,753,138
2,844,555
3,061,413
3,487,048
3,603,242
3,264,138
3,328,020
3,396,694
3,529,315
3,879,640
4,426,347
3,953,019
4,354,601
4,637,178
4,839,864
4,797,933
4,969,989
5,199,078
5,413,655
5,714,610
6,910,906
7,057,671
7,211,796
7,289,491
7,326,477
7,556,366
7,690,820
7,752,277
7,854,704
7,869,425
8,197,703
8,312,050
8,087,881
8,248,814
8,224,313
8,365,800
8,451,518
8,814,304
8,653,704
8,850,077
9,464,742
9,793,412
10,298,316
10,137,863
10,069,374
10,047,917
10,188,873
10,448,957
10,587,403
10,362,361
10,635,984
10,730,531
10,782,339
10,500,458
10,950,210
12,038,757
11,935,108
12,531,980
12,570,949
12,330,385
12,370,875
12,432,616
12,483,272
12,720,630
12,592,866
12,779,540
12,909,768
12,909,76812,779,54012,592,86612,720,63012,483,27212,432,61612,370,87512,330,38512,570,94912,531,98011,935,10812,038,75710,950,21010,500,45810,782,33910,730,53110,635,98410,362,36110,587,40310,448,95710,188,87310,047,91710,069,37410,137,86310,298,3169,793,4129,464,7428,850,0778,653,7048,814,3048,451,5188,365,8008,224,3138,248,8148,087,8818,312,0508,197,7037,869,4257,854,7047,752,2777,690,8207,556,3667,326,4777,289,4917,211,7967,057,6716,910,9065,714,6105,413,6555,199,0784,969,9894,797,9334,839,8644,637,1784,354,6013,953,0194,426,3473,879,6403,529,3153,396,6943,328,0203,264,1383,603,2423,487,0483,061,4132,844,5552,753,1382,693,3202,590,9682,528,3812,569,4832,532,5882,386,3862,207,7962,136,3552,121,7931,943,4011,838,9231,895,5731,793,0961,827,6481,668,8131,705,0591,680,1871,816,4651,636,6721,783,0981,732,6011,615,8561,565,1551,599,4941,436,6341,604,303
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,833,171
4,794,325
4,733,715
4,976,222
5,094,101
5,207,347
5,039,084
5,304,127
5,463,679
5,468,940
5,118,012
5,467,285
6,421,821
6,177,338
6,034,823
5,987,319
5,609,422
5,658,885
5,654,961
5,607,508
5,768,396
5,496,405
5,601,410
5,666,395
5,666,3955,601,4105,496,4055,768,3965,607,5085,654,9615,658,8855,609,4225,987,3196,034,8236,177,3386,421,8215,467,2855,118,0125,468,9405,463,6795,304,1275,039,0845,207,3475,094,1014,976,2224,733,7154,794,3254,833,171000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,410,652
1,463,635
1,492,026
1,405,450
1,378,740
1,367,296
1,277,830
1,765,181
1,865,458
1,854,253
1,628,916
1,519,837
2,004,017
1,632,665
1,768,532
1,397,214
1,368,670
1,304,784
1,438,077
1,404,433
1,507,694
1,349,723
1,460,027
1,584,294
1,584,2941,460,0271,349,7231,507,6941,404,4331,438,0771,304,7841,368,6701,397,2141,768,5321,632,6652,004,0171,519,8371,628,9161,854,2531,865,4581,765,1811,277,8301,367,2961,378,7401,405,4501,492,0261,463,6351,410,652000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
281,500
0
255,000
232,768
213,664
222,800
328,628
256,379
219,727
236,838
270,730
262,388
276,231
346,213
454,396
384,096
308,081
496,900
447,293
275,576
408,283
366,313
328,310
287,324
287,324328,310366,313408,283275,576447,293496,900308,081384,096454,396346,213276,231262,388270,730236,838219,727256,379328,628222,800213,664232,768255,0000281,500000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
442,633
464,510
480,932
394,012
445,516
493,735
443,603
428,119
521,094
471,487
473,397
427,363
488,793
449,275
459,378
418,496
526,702
508,173
528,363
565,453
661,049
670,401
677,236
604,638
653,664
725,408
710,620
736,763
872,138
1,092,978
984,812
721,023
771,403
950,869
1,143,188
919,105
1,030,589
1,010,739
1,129,626
800,514
1,057,891
1,085,055
978,004
984,384
1,254,924
1,179,681
1,206,019
1,069,485
1,224,144
1,239,061
1,334,617
1,148,478
1,361,622
1,334,931
1,165,777
1,048,963
1,158,563
1,141,754
1,260,312
1,144,639
1,499,347
1,430,951
1,443,281
1,335,521
1,295,950
1,341,836
1,479,333
1,672,963
1,984,398
1,633,414
1,698,819
1,651,802
1,446,720
1,501,374
1,509,041
1,699,670
1,681,514
1,674,312
1,714,049
1,543,653
1,909,944
2,065,875
2,123,097
1,699,234
1,877,309
1,589,787
1,631,272
1,297,974
1,402,484
1,548,078
1,314,053
1,252,230
1,481,523
1,481,5231,252,2301,314,0531,548,0781,402,4841,297,9741,631,2721,589,7871,877,3091,699,2342,123,0972,065,8751,909,9441,543,6531,714,0491,674,3121,681,5141,699,6701,509,0411,501,3741,446,7201,651,8021,698,8191,633,4141,984,3981,672,9631,479,3331,341,8361,295,9501,335,5211,443,2811,430,9511,499,3471,144,6391,260,3121,141,7541,158,5631,048,9631,165,7771,334,9311,361,6221,148,4781,334,6171,239,0611,224,1441,069,4851,206,0191,179,6811,254,924984,384978,0041,085,0551,057,891800,5141,129,6261,010,7391,030,589919,1051,143,188950,869771,403721,023984,8121,092,978872,138736,763710,620725,408653,664604,638677,236670,401661,049565,453528,363508,173526,702418,496459,378449,275488,793427,363473,397471,487521,094428,119443,603493,735445,516394,012480,932464,510442,633
       Other Current Assets 
35,576
29,942
31,986
12,308
14,355
21,720
43,398
16,640
17,631
16,903
8,772
4,105
11,022
14,226
41,070
46,000
64,458
68,399
89,998
27,701
43,992
43,080
27,162
37,975
43,579
37,004
42,978
35,147
41,822
25,740
81,267
14,176
33,076
22,011
32,017
69,743
81,582
65,409
77,165
107,028
140,073
148,001
171,665
154,152
128,849
189,714
262,689
100,894
175,221
175,301
187,337
190,363
211,183
238,422
249,751
243,685
231,707
236,450
216,904
229,428
236,027
199,332
203,022
164,023
178,380
199,397
190,098
153,127
254,335
189,878
443,341
132,821
272,390
326,433
342,963
143,768
289,223
173,454
201,487
143,849
294,181
179,863
436,685
236,035
326,500
187,664
194,156
120,654
107,023
233,411
93,929
49,848
75,294
75,29449,84893,929233,411107,023120,654194,156187,664326,500236,035436,685179,863294,181143,849201,487173,454289,223143,768342,963326,433272,390132,821443,341189,878254,335153,127190,098199,397178,380164,023203,022199,332236,027229,428216,904236,450231,707243,685249,751238,422211,183190,363187,337175,301175,221100,894262,689189,714128,849154,152171,665148,001140,073107,02877,16565,40981,58269,74332,01722,01133,07614,17681,26725,74041,82235,14742,97837,00443,57937,97527,16243,08043,99227,70189,99868,39964,45846,00041,07014,22611,0224,1058,77216,90317,63116,64043,39821,72014,35512,30831,98629,94235,576
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,212,651
5,354,856
5,380,056
5,323,277
5,331,858
5,266,851
5,313,399
5,382,445
5,482,925
5,616,937
5,757,770
6,497,157
6,583,630
6,720,963
6,711,990
6,777,656
6,875,764
6,952,234
7,096,460
7,178,130
7,243,373
7,243,3737,178,1307,096,4606,952,2346,875,7646,777,6566,711,9906,720,9636,583,6306,497,1575,757,7705,616,9375,482,9255,382,4455,313,3995,266,8515,331,8585,323,2775,380,0565,354,8565,212,651000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
321,190
379,428
403,159
513,399
551,934
594,543
627,370
652,042
681,122
681,294
693,696
668,983
702,710
708,718
705,285
712,869
743,977
837,516
863,878
1,012,907
1,011,754
1,094,226
1,120,781
1,176,563
1,149,626
1,228,808
1,204,158
1,242,547
1,188,140
1,232,936
1,206,812
1,241,856
1,190,337
1,215,899
1,155,734
1,213,277
1,181,595
1,223,954
1,202,263
1,278,817
1,220,457
1,307,701
1,245,697
1,440,321
1,353,327
1,584,137
1,514,042
2,031,297
2,017,486
2,625,326
2,589,898
3,135,244
2,908,221
3,054,339
3,274,089
3,511,481
3,663,349
3,717,645
3,794,852
4,017,917
4,026,931
4,043,297
4,048,480
4,156,427
4,188,276
4,219,135
4,310,182
4,391,520
4,348,095
4,399,777
4,415,106
4,434,831
4,395,879
4,420,955
4,414,992
4,459,213
4,386,876
4,376,728
4,394,189
4,513,355
4,543,821
4,598,146
4,740,919
5,359,570
5,376,225
5,480,222
5,471,738
5,618,034
5,618,448
5,689,821
5,811,040
6,019,443
6,071,422
6,071,4226,019,4435,811,0405,689,8215,618,4485,618,0345,471,7385,480,2225,376,2255,359,5704,740,9194,598,1464,543,8214,513,3554,394,1894,376,7284,386,8764,459,2134,414,9924,420,9554,395,8794,434,8314,415,1064,399,7774,348,0954,391,5204,310,1824,219,1354,188,2764,156,4274,048,4804,043,2974,026,9314,017,9173,794,8523,717,6453,663,3493,511,4813,274,0893,054,3392,908,2213,135,2442,589,8982,625,3262,017,4862,031,2971,514,0421,584,1371,353,3271,440,3211,245,6971,307,7011,220,4571,278,8171,202,2631,223,9541,181,5951,213,2771,155,7341,215,8991,190,3371,241,8561,206,8121,232,9361,188,1401,242,5471,204,1581,228,8081,149,6261,176,5631,120,7811,094,2261,011,7541,012,907863,878837,516743,977712,869705,285708,718702,710668,983693,696681,294681,122652,042627,370594,543551,934513,399403,159379,428321,190
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,124
12,124
12,124
12,124
12,124
12,124
12,841
12,841
5,055
5,055
5,055
5,055
0
0
0
0
0
0
0
0
36,031
36,031
36,031
36,031
27,907
27,907
27,907
27,907
18,680
18,680
18,68018,68027,90727,90727,90727,90736,03136,03136,03136,031000000005,0555,0555,0555,05512,84112,84112,12412,12412,12412,12412,12412,124000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
272,838
230,203
258,207
166,893
239,379
269,095
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000269,095239,379166,893258,207230,203272,838000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
9,448
9,348
9,449
28,901
28,851
28,528
28,862
28,420
28,244
11,009
12,334
23,260
23,075
23,089
22,866
28,425
28,268
3,365
27,617
3,014
25,956
2,644
28,194
5,262
32,899
4,864
38,050
4,490
43,267
4,116
42,443
3,740
41,618
3,366
40,812
3,024
40,018
2,681
39,225
2,337
38,431
2,038
75,231
2,260
145,568
2,081
204,684
51,563
221,061
55,638
277,123
53,887
395,088
392,541
380,563
347,469
343,810
414,381
411,574
409,274
406,530
430,211
427,345
437,013
434,051
425,535
423,518
418,914
415,722
401,517
399,503
407,726
419,019
41,619
408,153
406,895
405,926
403,293
419,158
409,753
440,891
511,460
507,261
728,805
778,502
779,564
762,271
747,676
727,567
785,313
764,874
744,304
728,667
728,667744,304764,874785,313727,567747,676762,271779,564778,502728,805507,261511,460440,891409,753419,158403,293405,926406,895408,15341,619419,019407,726399,503401,517415,722418,914423,518425,535434,051437,013427,345430,211406,530409,274411,574414,381343,810347,469380,563392,541395,08853,887277,12355,638221,06151,563204,6842,081145,5682,26075,2312,03838,4312,33739,2252,68140,0183,02440,8123,36641,6183,74042,4434,11643,2674,49038,0504,86432,8995,26228,1942,64425,9563,01427,6173,36528,26828,42522,86623,08923,07523,26012,33411,00928,24428,42028,86228,52828,85128,9019,4499,3489,448
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
194,436
285,571
55,742
36,503
90,100
72,521
4,474,730
47,093
101,307
129,979
170,501
67,466
95,075
114,705
120,560
55,773
127,892
92,841
134,310
46,453
71,859
71,85946,453134,31092,841127,89255,773120,560114,70595,07567,466170,501129,979101,30747,0934,474,73072,52190,10036,50355,742285,571194,436000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
970,688
801,607
971,238
956,659
1,001,674
1,109,878
1,156,801
1,006,962
1,182,083
1,046,676
1,070,459
1,040,335
1,208,993
1,171,212
1,272,009
1,193,239
1,290,108
1,445,873
1,432,713
1,475,568
1,643,859
1,765,541
1,790,549
1,751,072
1,792,735
1,908,495
1,966,352
1,970,821
2,129,051
2,231,951
1,982,976
1,451,879
1,411,459
1,574,573
1,293,981
1,018,307
1,079,644
782,442
836,943
773,858
789,436
788,206
760,014
798,631
745,804
1,026,988
824,945
860,734
779,649
955,839
899,481
1,075,945
1,121,675
1,237,060
1,176,260
1,307,726
1,572,895
1,685,149
1,510,684
1,633,695
1,613,269
1,674,725
1,522,733
1,822,480
1,616,506
1,874,993
1,879,323
2,014,237
2,019,007
1,938,248
1,860,802
1,963,815
2,027,397
2,278,513
2,341,315
2,110,158
2,245,183
3,026,631
2,898,374
2,470,417
2,664,558
3,331,762
3,013,649
3,349,948
3,176,493
3,141,393
2,707,415
2,722,757
2,660,022
2,651,013
2,693,536
2,793,146
2,843,314
2,843,3142,793,1462,693,5362,651,0132,660,0222,722,7572,707,4153,141,3933,176,4933,349,9483,013,6493,331,7622,664,5582,470,4172,898,3743,026,6312,245,1832,110,1582,341,3152,278,5132,027,3971,963,8151,860,8021,938,2482,019,0072,014,2371,879,3231,874,9931,616,5061,822,4801,522,7331,674,7251,613,2691,633,6951,510,6841,685,1491,572,8951,307,7261,176,2601,237,0601,121,6751,075,945899,481955,839779,649860,734824,9451,026,988745,804798,631760,014788,206789,436773,858836,943782,4421,079,6441,018,3071,293,9811,574,5731,411,4591,451,8791,982,9762,231,9512,129,0511,970,8211,966,3521,908,4951,792,7351,751,0721,790,5491,765,5411,643,8591,475,5681,432,7131,445,8731,290,1081,193,2391,272,0091,171,2121,208,9931,040,3351,070,4591,046,6761,182,0831,006,9621,156,8011,109,8781,001,674956,659971,238801,607970,688
   > Total Current Liabilities 
974,063
811,409
878,138
848,397
943,745
1,051,973
1,102,687
976,036
1,151,003
1,015,784
1,039,394
1,017,002
1,185,682
1,147,921
1,248,530
1,189,064
1,285,933
1,441,538
1,322,688
1,365,144
1,530,730
1,752,306
1,727,156
1,611,728
1,652,365
1,668,125
1,744,732
1,765,535
1,930,797
2,135,769
1,918,240
1,367,124
1,229,687
1,217,395
1,007,274
849,564
852,877
686,912
729,994
665,409
689,192
700,610
671,328
726,953
672,095
858,833
631,565
794,718
692,936
881,325
819,171
987,940
1,023,027
1,087,171
997,420
1,191,851
1,373,881
1,502,998
1,346,025
1,505,277
1,429,472
1,493,059
1,339,612
1,591,765
1,383,000
1,657,556
1,676,368
1,817,120
1,789,168
1,712,916
1,643,761
1,887,414
1,903,308
2,162,843
2,225,152
2,050,578
2,145,773
2,282,359
2,355,340
1,924,148
2,248,486
2,967,930
2,440,915
3,024,548
2,853,093
2,775,218
2,245,687
2,465,364
2,481,282
2,529,679
2,572,419
2,478,442
2,385,152
2,385,1522,478,4422,572,4192,529,6792,481,2822,465,3642,245,6872,775,2182,853,0933,024,5482,440,9152,967,9302,248,4861,924,1482,355,3402,282,3592,145,7732,050,5782,225,1522,162,8431,903,3081,887,4141,643,7611,712,9161,789,1681,817,1201,676,3681,657,5561,383,0001,591,7651,339,6121,493,0591,429,4721,505,2771,346,0251,502,9981,373,8811,191,851997,4201,087,1711,023,027987,940819,171881,325692,936794,718631,565858,833672,095726,953671,328700,610689,192665,409729,994686,912852,877849,5641,007,2741,217,3951,229,6871,367,1241,918,2402,135,7691,930,7971,765,5351,744,7321,668,1251,652,3651,611,7281,727,1561,752,3061,530,7301,365,1441,322,6881,441,5381,285,9331,189,0641,248,5301,147,9211,185,6821,017,0021,039,3941,015,7841,151,003976,0361,102,6871,051,973943,745848,397878,138811,409974,063
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,326
73,406
108,324
463,200
650,000
550,000
649,985
871,607
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000871,607649,985550,000650,000463,200108,32473,40678,326000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
78,326
73,406
108,324
463,200
650,000
550,000
649,985
871,607
851,470
801,358
250,305
280,594
331,170
230,806
176,124
150,142
50,058
100,518
50,063
50,063
200,203
200,203
200,223
235,259
235,259200,223200,203200,20350,06350,063100,51850,058150,142176,124230,806331,170280,594250,305801,358851,470871,607649,985550,000650,000463,200108,32473,40678,326000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
116,897
104,478
118,916
213,639
172,655
203,113
196,327
184,919
269,696
247,939
146,800
168,150
195,612
177,642
213,505
191,103
187,277
235,234
200,645
259,604
262,677
284,773
285,680
302,482
312,201
361,052
363,709
376,809
351,254
467,303
484,465
290,452
362,558
537,778
562,197
408,148
463,673
472,753
511,658
422,031
452,132
513,956
473,463
499,437
526,024
515,029
545,443
644,066
580,753
788,283
744,977
879,417
923,236
671,985
920,031
656,506
955,251
743,257
952,603
1,045,217
1,046,380
808,668
894,828
706,121
834,999
763,779
931,227
716,715
862,634
623,810
769,537
711,949
841,859
894,130
935,384
637,386
689,086
769,544
632,238
504,754
769,835
1,034,674
1,081,703
897,827
1,310,882
810,930
1,015,807
1,061,227
1,044,628
713,856
1,002,018
1,150,150
1,149,272
1,149,2721,150,1501,002,018713,8561,044,6281,061,2271,015,807810,9301,310,882897,8271,081,7031,034,674769,835504,754632,238769,544689,086637,386935,384894,130841,859711,949769,537623,810862,634716,715931,227763,779834,999706,121894,828808,6681,046,3801,045,217952,603743,257955,251656,506920,031671,985923,236879,417744,977788,283580,753644,066545,443515,029526,024499,437473,463513,956452,132422,031511,658472,753463,673408,148562,197537,778362,558290,452484,465467,303351,254376,809363,709361,052312,201302,482285,680284,773262,677259,604200,645235,234187,277191,103213,505177,642195,612168,150146,800247,939269,696184,919196,327203,113172,655213,639118,916104,478116,897
       Other Current Liabilities 
141,671
102,106
74,938
95,381
100,877
135,470
103,693
83,837
73,827
83,495
79,274
34,392
46,796
57,006
64,762
53,249
59,427
71,090
103,510
490
35,203
94,683
75,826
55,446
42,364
65,473
65,223
102,636
148,953
188,143
118,572
192,119
191,076
161,644
218,672
300,566
258,354
185,159
218,336
243,378
237,060
186,654
197,865
227,516
146,071
343,804
86,122
150,652
112,183
93,042
74,194
108,523
99,790
415,186
77,388
435,345
68,629
459,741
93,423
110,059
83,091
384,392
144,784
581,990
293,001
627,702
386,229
811,304
593,166
563,946
510,106
279,759
48,980
49,109
49,077
329,967
531,823
278,645
869,784
434,509
791,871
674,112
752,147
927,890
772,396
1,063,166
671,970
7,196
3,509
738,815
3,294
4,448
4,221
4,2214,4483,294738,8153,5097,196671,9701,063,166772,396927,890752,147674,112791,871434,509869,784278,645531,823329,96749,07749,10948,980279,759510,106563,946593,166811,304386,229627,702293,001581,990144,784384,39283,091110,05993,423459,74168,629435,34577,388415,18699,790108,52374,19493,042112,183150,65286,122343,804146,071227,516197,865186,654237,060243,378218,336185,159258,354300,566218,672161,644191,076192,119118,572188,143148,953102,63665,22365,47342,36455,44675,82694,68335,203490103,51071,09059,42753,24964,76257,00646,79634,39279,27483,49573,82783,837103,693135,470100,87795,38174,938102,106141,671
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,090
115,669
116,162
59,580
99,409
744,271
543,034
546,269
416,071
363,832
572,733
325,401
323,400
366,175
461,728
257,393
178,740
121,335
121,117
314,704
458,162
458,162314,704121,117121,335178,740257,393461,728366,175323,400325,401572,733363,832416,071546,269543,034744,27199,40959,580116,162115,669124,090000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
19,100
18,700
18,700
18,701
18,700
18,701
18,700
18,700
18,900
20,271
20,270
20,271
20,480
1,235
1,235
1,395
7,085
7,484
10,189
10,295
10,453
14,554
15,580
15,580
16,830
13,260
12,849
12,333
11,817
11,615
13,003
12,450
12,161
20,812
45,710
52,168
52,137
41,209
44,664
44,020
47,376
32,995
36,957
36,955
38,084
33,687
44,667
35,810
37,062
41,643
54,326
54,403
56,471
60,307
64,882
67,056
65,773
61,487
59,013
57,626
55,198
56,101
54,672
50,856
50,369
47,682
46,775
76,942
69,022
64,631
63,048
56,198
57,839
59,580
49,409
43,534
42,447
45,623
65,426
63,456
72,407
73,906
71,952
64,883
60,347
0
0
55,794
0
0
0
00055,7940060,34764,88371,95273,90672,40763,45665,42645,62342,44743,53449,40959,58057,83956,19863,04864,63169,02276,94246,77547,68250,36950,85654,67256,10155,19857,62659,01361,48765,77367,05664,88260,30756,47154,40354,32641,64337,06235,81044,66733,68738,08436,95536,95732,99547,37644,02044,66441,20952,13752,16845,71020,81212,16112,45013,00311,61511,81712,33312,84913,26016,83015,58015,58014,55410,45310,29510,1897,4847,0851,3951,2351,23520,48020,27120,27020,27118,90018,70018,70018,70118,70018,70118,70018,70019,10000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
754
708
1,034
904
28,635
28,537
28,259
27,623
27,536
27,897
27,180
77
473
390
414
2,354
5,150
5,893
0
0
7,551
0
0
0
0007,551005,8935,1502,3544143904737727,18027,89727,53627,62328,25928,53728,6359041,034708754000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
632,195
633,753
626,868
599,938
605,746
614,633
618,113
619,102
624,870
627,771
629,204
624,698
613,705
617,278
619,359
640,315
648,767
672,027
701,093
724,662
735,217
760,225
772,435
771,054
792,877
780,118
782,225
869,091
926,296
1,248,128
1,611,919
1,799,447
1,905,213
1,810,709
2,224,290
2,849,127
3,335,020
3,158,043
3,510,467
3,857,212
4,045,256
4,004,427
4,204,274
4,390,892
4,659,076
4,678,177
6,075,506
6,186,443
6,416,712
6,317,112
6,411,242
6,458,133
6,547,103
6,492,814
6,656,153
6,538,251
6,604,787
6,606,821
6,555,984
6,595,318
6,592,312
6,669,735
6,906,149
6,978,221
7,026,797
6,966,390
6,977,794
7,289,230
7,781,880
7,712,462
7,730,784
7,646,790
7,727,367
7,736,945
7,817,819
7,860,816
8,009,371
7,330,269
7,516,490
7,674,561
7,947,843
8,215,935
8,456,476
8,779,106
9,042,540
8,869,770
9,165,509
9,259,882
9,401,601
9,650,133
9,513,445
9,630,716
9,738,930
9,738,9309,630,7169,513,4459,650,1339,401,6019,259,8829,165,5098,869,7709,042,5408,779,1068,456,4768,215,9357,947,8437,674,5617,516,4907,330,2698,009,3717,860,8167,817,8197,736,9457,727,3677,646,7907,730,7847,712,4627,781,8807,289,2306,977,7946,966,3907,026,7976,978,2216,906,1496,669,7356,592,3126,595,3186,555,9846,606,8216,604,7876,538,2516,656,1536,492,8146,547,1036,458,1336,411,2426,317,1126,416,7126,186,4436,075,5064,678,1774,659,0764,390,8924,204,2744,004,4274,045,2563,857,2123,510,4673,158,0433,335,0202,849,1272,224,2901,810,7091,905,2131,799,4471,611,9191,248,128926,296869,091782,225780,118792,877771,054772,435760,225735,217724,662701,093672,027648,767640,315619,359617,278613,705624,698629,204627,771624,870619,102618,113614,633605,746599,938626,868633,753632,195
   Common Stock
230,800
300,040
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
450,060
520,060
520,060
520,060
520,060
520,060
936,108
936,108
936,108
936,108
936,108
936,108
936,108
936,108
936,108
936,108
936,108
936,108
962,848
962,848
962,848
962,348
965,608
965,608
965,608
965,258
965,258
965,258
965,258
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
965,128
0
0
964,975
0
0
0
000964,97500965,128965,128965,128965,128965,128965,128965,128965,128965,128965,128965,128965,128965,128965,258965,258965,258965,258965,608965,608965,608962,348962,848962,848962,848936,108936,108936,108936,108936,108936,108936,108936,108936,108936,108936,108936,108520,060520,060520,060520,060520,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060450,060300,040230,800
   Retained Earnings 
54,333
50,540
34,121
7,312
13,120
22,007
25,078
21,429
27,197
30,090
31,450
23,622
13,370
17,508
20,147
19,862
29,610
55,314
82,255
87,139
97,694
121,702
136,623
125,337
144,331
131,573
133,660
178,130
255,199
581,701
948,282
993,463
1,095,668
995,726
1,410,339
1,710,731
2,008,915
1,932,207
2,218,205
2,324,546
2,578,667
2,605,381
2,818,074
2,873,987
3,153,112
3,148,052
3,325,658
3,328,664
3,509,020
3,426,014
3,491,723
3,452,109
4,443,818
4,421,575
4,507,118
4,379,749
4,350,881
4,458,443
4,512,497
4,485,384
4,550,106
4,630,685
4,843,640
4,888,680
4,912,691
4,839,303
4,880,595
5,002,285
5,467,626
5,393,756
5,439,617
5,289,663
4,380,039
4,384,139
4,463,494
5,611,470
5,759,908
5,080,204
5,273,704
5,370,569
5,637,438
5,657,781
5,900,775
6,195,480
6,456,023
6,267,575
6,361,442
4,830,100
4,943,651
6,688,821
4,967,392
5,034,690
5,144,340
5,144,3405,034,6904,967,3926,688,8214,943,6514,830,1006,361,4426,267,5756,456,0236,195,4805,900,7755,657,7815,637,4385,370,5695,273,7045,080,2045,759,9085,611,4704,463,4944,384,1394,380,0395,289,6635,439,6175,393,7565,467,6265,002,2854,880,5954,839,3034,912,6914,888,6804,843,6404,630,6854,550,1064,485,3844,512,4974,458,4434,350,8814,379,7494,507,1184,421,5754,443,8183,452,1093,491,7233,426,0143,509,0203,328,6643,325,6583,148,0523,153,1122,873,9872,818,0742,605,3812,578,6672,324,5462,218,2051,932,2072,008,9151,710,7311,410,339995,7261,095,668993,463948,282581,701255,199178,130133,660131,573144,331125,337136,623121,70297,69487,13982,25555,31429,61019,86220,14717,50813,37023,62231,45030,09027,19721,42925,07822,00713,1207,31234,12150,54054,333
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-121,611-123,120-125,480-125,480-180,662-184,177-187,982-187,982000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
181,079
145,961
124,519
-1,618
164
-70
1,397
1,514
3,428
3,563
412
-3,373
-4,910
-7,783
-13,994
-17,774
-16,916
-15,588
0
0
7,986
0
0
0
0007,98600-15,588-16,916-17,774-13,994-7,783-4,910-3,3734123,5633,4281,5141,397-70164-1,618124,519145,961181,079000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue7,794,146
Cost of Revenue-5,269,879
Gross Profit2,524,2672,524,267
 
Operating Income (+$)
Gross Profit2,524,267
Operating Expense-7,639,034
Operating Income155,112-5,114,767
 
Operating Expense (+$)
Research Development860,072
Selling General Administrative1,163,085
Selling And Marketing Expenses0
Operating Expense7,639,0342,023,157
 
Net Interest Income (+$)
Interest Income16,512
Interest Expense-28,336
Other Finance Cost-7,225
Net Interest Income-19,049
 
Pretax Income (+$)
Operating Income155,112
Net Interest Income-19,049
Other Non-Operating Income Expenses0
Income Before Tax (EBT)363,279155,112
EBIT - interestExpense = -28,336
429,640
457,975
Interest Expense28,336
Earnings Before Interest and Taxes (EBIT)0391,614
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax363,279
Tax Provision-86,485
Net Income From Continuing Ops276,794276,794
Net Income429,640
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net019,049
 

Technical Analysis of Zhejiang Medicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Medicine Co Ltd. The general trend of Zhejiang Medicine Co Ltd is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Medicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Medicine Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 11.43 < 11.45 < 11.46.

The bearish price targets are: 10.98 > 10.03 > 9.99.

Tweet this
Zhejiang Medicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Medicine Co Ltd. The current macd is 0.36699803.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Medicine Co Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Medicine Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Medicine Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Medicine Co Ltd. The current adx is 30.60.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Medicine Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Zhejiang Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Medicine Co Ltd. The current sar is 9.29566996.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Medicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Medicine Co Ltd. The current rsi is 76.31. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Zhejiang Medicine Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Medicine Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Medicine Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Medicine Co Ltd Daily Stochastic Oscillator ChartZhejiang Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Medicine Co Ltd. The current cci is 205.53.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Medicine Co Ltd. The current cmo is 67.18.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Medicine Co Ltd. The current willr is -29.93197279.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Medicine Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Medicine Co Ltd Daily Williams %R ChartZhejiang Medicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Medicine Co Ltd.

Zhejiang Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Medicine Co Ltd. The current atr is 0.38619777.

Zhejiang Medicine Co Ltd Daily Average True Range (ATR) ChartZhejiang Medicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Medicine Co Ltd. The current obv is 459,069,564.

Zhejiang Medicine Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Medicine Co Ltd. The current mfi is 85.10.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Zhejiang Medicine Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Medicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-10STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Zhejiang Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5076.309
Ma 20Greater thanMa 509.683
Ma 50Greater thanMa 1009.578
Ma 100Greater thanMa 2009.898
OpenGreater thanClose11.260
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Medicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Medicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Medicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Medicine Co Ltd

I send you an email if I find something interesting about Zhejiang Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Medicine Co Ltd.

Receive notifications about Zhejiang Medicine Co Ltd in your mailbox!